IR Topics

Riken Vitamin Acquires Site for New Factory

Notice Regarding the Acquisition Status of Own Shares 97396

Financial Results Briefing for FY2025 (with Script / Q&A) 

Presentation Material of Financial Results Briefing for FY2025 1564232

Notice Regarding Dividend of Surplus 111945

Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 528476

Notice Regarding Acquisition of Own Shares 99754

Financial Results Supplementary Materials for FY2025 429748

Notice Regarding Changes in Representative Director and Directors 97985

Notice Regarding the Status and Completion of Acquisition of Own Shares 90543

Notice Regarding the Acquisition Status of Own Shares 89386

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2025 203915

Notice of Revisions to Consolidated Full-Year Results Forecast 112633

Financial Results Supplementary Materials for Q3 FY2025 411514

Notice Regarding the Acquisition Status of Own Shares 89634

Notice Regarding the Acquisition Status of Own Shares 89865

Notice Regarding the Acquisition Status of Own Shares 89475

Financial Results for 1H FY2025 Briefing (with Script / Q&A) 

Presentation Material of Financial Results Briefing for 1H FY2025 1971240

Riken Vitamin USA to Relocate Office to Texas

Integrated Report 2025

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2025 252845

Financial Results Supplementary Materials for 1H FY2025 539194

Notice Regarding the Acquisition Status of Own Shares 89917

Notice Regarding Dividend of Surplus (Interim Dividend) 155666

Notice Regarding the Acquisition Status of Own Shares 111260

Notice Regarding the Acquisition Status of Own Shares 89619

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2025 252603

Financial Results Supplementary Materials for Q1 FY2025 576617

Notice Regarding the Acquisition Status of Own Shares 89840

Notice Regarding the Acquisition Status of Own Shares 89876

Notice Regarding the Acquisition Status of Own Shares 89663

Financial Results for FY2024 and Medium-Term Management Plan Briefing (with Script / Q&A) 

Presentation Materials of Financial Results for FY2024 and Medium-Term Management Plan 1967702

Notice Regarding Dividend of Surplus 154855

Summary of Consolidated Financial Results for the Year Ended March 31, 2025 325781

Notice of Revision to Year-end Dividend Forecast 129492

Notice Regarding the Formulation of Medium-Term Management Plan 2027 1407808

Supplementary Materials for FY2024 Financial Results 576241

Notice Regarding Changes in Representative Directors and Directors 117428

Notice Regarding Acquisition of Own Shares 88335

Notice Regarding Results of Acquisition of Own Shares Through ToSTNeT-3 109465

Notice Regarding Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) and
Cancellation of Treasury Shares 94404

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2024 254253

Notice of Revisions to Consolidated Full-Year Results Forecast and Year-end Dividend Forecast 96750

Supplementary Material of Financial Results for Q3 FY2024 361392

Notice Regarding Recording of Extraordinary Income(Gain on Sale of Investment Securities) 89847

Financial Results Briefing for 1H FY2024 (with Script / Q&A)

Presentation Material of Financial Results Briefing for 1H FY2024 3221611

Integrated Report 2024

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024 254221

Supplementary Material of Financial Results for 1H FY2024 488654

Notice Regarding Dividend of Surplus (Interim Dividend) 135306

Notice Regarding Establishment of Subsidiaries 110395

Notice Regarding Disposal of Treasury Shares through Third-Party Allotment 140155

Notice Regarding the Continuation of and Additional Contributions to the Performance-Linked Share-Based Remuneration System for Directors and Incentive Plan for Executive Officers 140174

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2024 250246

Supplementary Material of Financial Results for Q1 FY2024 489224

Financial Results Briefing for FY2023 (with Script / Q&A)

Notice Regarding Dividend of Surplus 155332

Summary of Consolidated Financial Results for the Year Ended March 31, 2024 304382

Notice of Revision to Year-end Dividend Forecast 129202

FY2023 Supplementary Material 398178

Notice Regarding Results of Acquisition of Own Shares Through ToSTNeT-3 and Change in Major Shareholder 120759

Notice Regarding Dissolution of Capital and Business Alliance 143958

Notice Regarding Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) 91800

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023 250587

Notice of Revisions to Consolidated Full-Year Results Forecast and Year-end Dividend Forecast 116192

Expansion of pork extract production for ramen soup in North America

Notice Regarding Recording of Extraordinary Income (Gain on Sale of Investment Securities) 85951

Establishment of an Application Center in North America to strengthen proposals for food improvers

Financial Results Briefing for 1H FY2023 (with Script / Q&A)

Integrated Report 2023

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2023 203604

Notice of Difference between Forecast and Actual Results for the First Half and Revision to Full-Year Results Forecast 96142

Notice Regarding Dividend of Surplus (Interim Dividend) and Revision to Year-End Dividend Forecast 93220

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023 202054

Financial Results Briefing for FY2022 (with Script / Q&A)

Summary of Consolidated Financial Results for the Year Ended March 31, 2023 254541

Notice of Revision to Year-end Dividend Forecast 108463

Notice of Revision to Consolidated Full-Year Results Forecast and Year-end Dividend Forecast 137983

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2022 214571

Financial Results Briefing for 1H FY2022 (with Script / Q&A)

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2022 205518

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2022 203787

Financial Results Briefing for FY2021 and Medium-Term Management Plan Presentation (with Script / Q&A)

Summary of Consolidated Financial Results for the Year Ended March 31, 2022 257851

Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2021 380470

Financial Results Briefing for the First Half of the Fiscal Year Ending March 31, 2022

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2021 379431

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2021 205472

Financial Results Briefing for the Fiscal Year Ended March 31, 2021

Summary of Consolidated Financial Results for the Year Ended March 31, 2021 275826